Trikafta is a Kit in the Human Prescription Drug category. It is labeled and distributed by Vertex Pharmaceuticals Incorporated. The primary component is .
Product ID | 51167-106_12edff26-ed48-49e6-b1b8-887447e6eac3 |
NDC | 51167-106 |
Product Type | Human Prescription Drug |
Proprietary Name | Trikafta |
Generic Name | Elexacaftor, Tezacaftor, And Ivacaftor |
Dosage Form | Kit |
Marketing Start Date | 2021-06-08 |
Marketing Category | NDA / |
Application Number | NDA212273 |
Labeler Name | Vertex Pharmaceuticals Incorporated |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-06-08 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
51167-106 | Trikafta | Elexacaftor, Tezacaftor, and Ivacaftor |
51167-331 | Trikafta | Elexacaftor, Tezacaftor, and Ivacaftor |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
TRIKAFTA 88031776 not registered Live/Pending |
Vertex Pharmaceuticals Incorporated 2018-07-10 |
TRIKAFTA 87924202 5938974 Live/Registered |
Vertex Pharmaceuticals Incorporated 2018-05-16 |
TRIKAFTA 87893193 5938914 Live/Registered |
Vertex Pharmaceuticals Incorporated 2018-04-25 |